Company Overview of KAEL-GemVax Co., Ltd.
KAEL-GemVax Co., Ltd. develops and commercializes therapeutic cancer vaccines and infectious disease vaccines. It provides lung, melanoma, leukemia, pancreatic, prostate, and breast/ovarian cancer vaccines; and malaria, HIV, hepatitis, and influenza diseases vaccines. KAEL-GemVax Co., Ltd. was formerly known as GemVax Co., Ltd. The company was founded in 2001 and is based in Seongnam-si, South Korea. KAEL-GemVax Co., Ltd. operates as a subsidiary of GemVax & KAEL Co.,Ltd.
939 Unjung-dong Bundang-gu
Founded in 2001
82 2 544 6221
82 2 3443 4997
Key Executives for KAEL-GemVax Co., Ltd.
Similar Private Companies By Industry
|Korea Vaccine Co., Ltd.||Asia|
|Eisai Korea Inc.||Asia|
|ST Pharm Co. Ltd.||Asia|
|Jungwoo Pharmaceutical Co., Ltd.||Asia|
|Korea Otsuka Pharmaceutical Co., Ltd.||Asia|
Recent Private Companies Transactions
January 20, 2014
To contact KAEL-GemVax Co., Ltd., please visit www.kaelgemvax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.